2001–2021 Comparative Persistence of Oral Antipsychotics in Patients Initiating Treatment: Superiority of Clozapine in Time-to-Treatment Discontinuation
Pharmacopsychiatry · 01.07.2025 · 58 (04) · 159-169
DOI: 10.1055/a-2437-4366 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Pharmacopsychiatry, erschienen am 01.07.2025. Verfasst von Alberto Parabiaghi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unit for Quality of Care and Rights Promotion in Mental Health, Department of Health Policy, Istituto di Ricerche Farmacologiche "Mario Negri" - IRCC…. Hauptthemen laut MEDLINE: Antipsychotic Agents, Clozapine, Psychotic Disorders, Time-to-Treatment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Background
Continuous antipsychotic (AP) therapy is crucial for managing psychotic disorders, and its early interruption reflects the drugʼs failure. Real-world epidemiological research is essential for confirming experimental data and generating new research hypotheses.
Methods
The persistence of oral APs in a large population sample from 2000 to 2021 was analyzed by comparing AP prescriptions over this period across four Italian provinces, using dispensing data linked via a record-linkage procedure among regional healthcare utilization databases. We calculated personalized daily dosages and assessed time-to-treatment discontinuation over a 3-month period for patients initiating AP treatment. Treatment persistence was evaluated using Kaplan-Meier curves and Cox regression, with adjustments for age and sex.
Results
Second-generation antipsychotics (SGAs) were favored over first-generation antipsychotics (FGAs), with olanzapine as the most prescribed. Within the study time frame, 42,434 individuals were prescribed a new continuous AP regimen. The analysis revealed 24 significant differences within 28 comparisons. As a class, SGAs demonstrated better treatment persistence than FGAs (HR: 0.76; 95%CI: 0.73, 0.79). Clozapine stood out for its superior persistence, surpassing all other SGAs, notably olanzapine (HR: 0.85; 95%CI: 0.79–0.91) and risperidone (HR: 0.80; 95%CI: 0.74–0.87). Olanzapine and aripiprazole showed better results than both risperidone and quetiapine. Quetiapine showed inferior 3-month persistence in all pairwise comparisons.
Conclusion
The study results provide insight into the performance dynamics among SGAs: clozapine, despite being one of the less frequently dispensed APs in our sample, emerged as a significant prescription choice. The significance of pharmacoepidemiological studies in complementing experimental findings is also underscored.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Unit for Quality of Care and Rights Promotion in Mental Health, Department of Health Policy, Istituto di Ricerche Farmacologiche "Mario Negri" - IRCCS, Milan, Italy.
- Laboratory of Geriatric Epidemiology, Department of Health Policy, Istituto di Ricerche Farmacologiche "Mario Negri" - IRCCS, Milan, Italy.
- Laboratory for Assessing Quality of Care and Services, Department of Health Policy, Istituto di Ricerche Farmacologiche "Mario Negri" - IRCCS, Milan, Italy.
- Directorate General for Health, Lombardy Region, Milan, Italy.
ORCID-Profile: Alberto Parabiaghi
Zitieren
APA
Parabiaghi, A., Galbussera, A. A., D'Avanzo, B., Tettamanti, M., Fortino, I., & Barbato, A. (2025). 2001–2021 Comparative Persistence of Oral Antipsychotics in Patients Initiating Treatment: Superiority of Clozapine in Time-to-Treatment Discontinuation. Pharmacopsychiatry, 58(04), 159-169. https://doi.org/10.1055/a-2437-4366
Vancouver
Parabiaghi A, Galbussera AA, D'Avanzo B, Tettamanti M, Fortino I, Barbato A. 2001–2021 Comparative Persistence of Oral Antipsychotics in Patients Initiating Treatment: Superiority of Clozapine in Time-to-Treatment Discontinuation. Pharmacopsychiatry. 2025;58(04):159-169. doi:10.1055/a-2437-4366
BibTeX
@article{Parabiaghi2025,
author = {Parabiaghi, Alberto and Galbussera, Alessia A and D'Avanzo, Barbara and Tettamanti, Mauro and Fortino, Ida and Barbato, Angelo},
title = {2001–2021 Comparative Persistence of Oral Antipsychotics in Patients Initiating Treatment: Superiority of Clozapine in Time-to-Treatment Discontinuation},
journal = {Pharmacopsychiatry},
year = {2025},
volume = {58},
number = {04},
pages = {159--169},
doi = {10.1055/a-2437-4366}
}
EUVIMED